References
- Hill NR , FatobaST, OkeJLet al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS ONE11(7), e0158765 (2016).
- Gansevoort RT , Correa-RotterR, HemmelgarnBRet al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms and prevention. Lancet382(9889), 339–352 (2013).
- Levey AS , CoreshJ. Chronic kidney disease. Lancet379(9811), 165–180 (2012).
- Levin A , StevensPE, BilousRWet al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Supplements3(1), 1–150 (2013).
- Eckardt K , CoreshJ, DevuystOet al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet382(9887), 158–169 (2013).
- James MT , HemmelgarnBR, TonelliM. Early recognition and prevention of chronic kidney disease. Lancet375(9722), 1296–1309 (2010).
- Levey AS , BeckerC, InkerLA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA313(8), 837–846 (2015).
- Al-Wakeel J . Accuracy and precision of the CKD-EPI and MDRD predictive equations compared with glomerular filtration rate measured by inulin clearance in a saudi population. Ann. Saudi Med.36(2), 128–134 (2016).
- Inker LA , TighiouartH, CoreshJet al. GFR estimation using ß-trace protein and ß2-microglobulin in CKD. Am. J. Kidney Dis.67(1), 40–48 (2016).
- Edwards TL , BrowneCM, SchoonA, CoxC, PolingA. Animal olfactory detection of human diseases: guidelines and systematic review. J. Vet. Behav.20, 59–73 (2017).
- de Lacy Costello Amann A , Al-KatebHet al. A review of the volatiles from the healthy human body. J. Breath Res.8(1), 014001–014001 (2014).
- Shirasu M , TouharaK. The scent of disease: volatile organic compounds of the human body related to disease and disorder. J. Biochem.150(3), 257–266 (2011).
- Buszewski B , KesyM, LigorT, AmannA. Human exhaled air analytics: biomarkers of diseases. Biomed. Chromatogr.21(6), 553–566 (2007).
- Mochalski P , KingJ, HaasM, UnterkoflerK, AmannA, MayerG. Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease. BMC Nephrol.15, 43–43 (2014).
- Pagonas N , VautzW, SeifertLet al. Volatile organic compounds in uremia. PLoS ONE7(9), e46258–e46258 (2012).
- Di Francesco F , FuocoR, TrivellaMG, CeccariniA. Breath analysis: trends in techniques and clinical applications. Microchemical J.79(1), 405–410 (2005).
- Bijland LR , BomersMK, SmuldersYM. Smelling the diagnosis: a review on the use of scent in diagnosing disease. Neth. J. Med.71(6), 300–307 (2013).
- Hackner K , PleilJ. Canine olfaction as an alternative to analytical instruments for disease diagnosis: understanding ‘dog personality’ to achieve reproducible results. J. Breath Res.11(1), 012001–012001 (2017).
- Bhandare PB , PendbhajeNS, NarangAP. Electronic nose: a review. Res. Rev. J. Eng. Technol.2(4), 1708 (2013).
- Wilson AD , BaiettoM. Advances in electronic-nose technologies developed for biomedical applications. Sensors (Basel)11(1), 1105–1176 (2011).
- Röck F , BarsamN, WeimarU. Electronic nose: current status and future trends. Chem. Rev.108(2), 705–725 (2008).
- Casalinuovo IA , DiPierro D, ColettaM, DiFrancesco P. Application of electronic noses for disease diagnosis and food spoilage detection. Sensors6(11), 1428–1439 (2006).
- Capelli L , TavernaG, BelliniAet al. Application and uses of electronic noses for clinical diagnosis on urine samples: a review. Sensors (Basel)16(10), (2016).
- Di Natale C , MantiniA, MacagnanoA, AntuzziD, PaolesseR, D'AmicoA. Electronic nose analysis of urine samples containing blood. Physiol. Meas.20(4), 377–384 (1999).
- Niemi RJ , RoineAN, EräviitaE, KumpulainenPS, MäenpääJU, OksalaN. FAIMS analysis of urine gaseous headspace is capable of differentiating ovarian cancer. Gynecol. Oncol.151(3), 519–524 (2018).
- Leskinen Y , LehtimäkiT, LoimaalaAet al. Homocysteine and carotid atherosclerosis in chronic renal failure – the confounding effect of renal function. Atherosclerosis175(2), 315–323 (2004).
- Leskinen Y , SaleniusJP, LehtimäkiT, HuhtalaH, SahaH. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am. J. Kidney Dis.40(3), 472–479 (2002).
- Levey AS , StevensLA, SchmidCHet al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med.150(9), 604–612 (2009).
- Covington JA , vandS, EdgeASL, BoyleB, SavageRS, ArasaradnamRP. The application of FAIMS gas analysis in medical diagnostics. Analyst140(20), 6775–6781 (2015).
- Bishop CM . Pattern Recognition and Machine Learning.Springer Science+Business Media, LCC, NY, USA (2006).
- Voss A , BaierV, ReischRet al. Smelling renal dysfunction via electronic nose. Ann. Biomed. Eng.33(5), 656–660 (2005).
- Lin Y , GuoH, ChangY, KaoM, WangH, HongR. Application of the electronic nose for uremia diagnosis. Sensors Actuators B Chem.76(1–3), 177–180 (2001).
- Haick H , HakimM, PatrascuMet al. Sniffing chronic renal failure in rat model by an array of random networks of single-walled carbon nanotubes. ACS Nano3(5), 1258–1266 (2009).
- Cumeras R , FiguerasE, DavisCE, BaumbachJI, GràciaI. Review on ion mobility spectrometry. part 2: hyphenated methods and effects of experimental parameters. Analyst140(5), 1391–1410 (2015).
- Combs S , BerlT. Dysnatremias in patients with kidney disease. Am. J. Kidney Dis.63(2), 294–303 (2014).
- Raphael KL , CarrollDJ, MurrayJ, GreeneT, BeddhuS. Urine ammonium predicts clinical outcomes in hypertensive kidney disease. J. Am. Soc. Nephrol.28(8), 2483–2490 (2017).
- Blanchet L , SmolinskaA, BaranskaAet al. Factors that influence the volatile organic compound content in human breath. J. Breath Res.11(1), 016013–016013 (2017).
- Dhima M , SalinasTJ, WermersRA, WeaverAL, KokaS. Preference changes of adult outpatients for giving saliva, urine and blood for clinical testing after actual sample collection. J. Prosthodont. Res.57(1), 51–56 (2013).
- Esfahani S , SagarNM, KyrouIet al. Variation in gas and volatile compound emissions from human urine as it ages, measured by an electronic nose. Biosensors (Basel)6(1), 4 (2016).
- Kohn MA , CarpenterCR, NewmanTB. Understanding the direction of bias in studies of diagnostic test accuracy. Acad. Emerg. Med.20(11), 1194–1206 (2013).
- Verbeke F , SiwyJ, Van BiesenWet al. The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease. Nephrol. Dial. Transplant. doi:10.1111/acem.12255 (2019) ( Epub ahead of print).
- Colombo M , McGurnaghanSJ, BlackbournLAKet al. Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetes. Diabetologia63(4), 788–798 (2020).
- Moyer VA1 . U.S. Preventive Services Task Force. Screening for chronic kidney disease: U.S. preventive services task force recommendation statement. Ann. Intern. Med.157(8), 50 (2012).
- Manns B , HemmelgarnB, TonelliMet al. Population-based screening for chronic kidney disease: cost–effectiveness study. BMJ341, 5869 (2010).